Since our last HTB there have been some significant steps forward in terms of treatment access in resource poor settings including the announcement from the Clinton Foundation of a price of as low 36 cents per day for triple combination therapy – covered in the treatment access news.

Closer to home, we report from the 9th European AIDS Conference (EACS), held this Autumn in Warsaw.

FTC has been approved in Europe, and ataznavir received a positive opinion from the CPMP but only for treatment of experienced patients and only when boosted with ritonavir.

Even closer, CHIVA and i-Base organised a workshop to discuss the transition of HIV-positive adolescents from paediatric to adult care. We will be producing a report from the meeting that will be available in early 2004…

This issue of HTB is a double issue, so may we take the opportunity to wish all our readers a very happy Christmas and new Year…

The next issue of HTB will be dated February 2004 and distributed in the last week of January.